162 related articles for article (PubMed ID: 8675220)
1. In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice.
Bost KL; Holton RH; Cain TK; Clements JD
Immunology; 1996 Apr; 87(4):633-41. PubMed ID: 8675220
[TBL] [Abstract][Full Text] [Related]
2. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.
Bost KL; Clements JD
Infect Immun; 1995 Mar; 63(3):1076-83. PubMed ID: 7868230
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
Ruedl C; Rieser C; Kofler N; Wick G; Wolf H
Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827
[TBL] [Abstract][Full Text] [Related]
4. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.
Nakagawa I; Takahashi I; Kiyono H; McGhee JR; Hamada S
J Infect Dis; 1996 Jun; 173(6):1428-36. PubMed ID: 8648216
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
9. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
12. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.
Mason HS; Haq TA; Clements JD; Arntzen CJ
Vaccine; 1998 Aug; 16(13):1336-43. PubMed ID: 9682399
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.
Karaman S; Cunnick J; Wang K
Mol Biotechnol; 2006 Jan; 32(1):31-42. PubMed ID: 16382180
[TBL] [Abstract][Full Text] [Related]
14. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
Dickinson BL; Clements JD
Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
[TBL] [Abstract][Full Text] [Related]
16. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
Nawar HF; Greene CJ; Lee CH; Mandell LM; Hajishengallis G; Connell TD
Vaccine; 2011 Jan; 29(4):721-7. PubMed ID: 21095251
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
18. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
19. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
Di Tommaso A; Saletti G; Pizza M; Rappuoli R; Dougan G; Abrignani S; Douce G; De Magistris MT
Infect Immun; 1996 Mar; 64(3):974-9. PubMed ID: 8641809
[TBL] [Abstract][Full Text] [Related]
20. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
